Funds
ADVFN has launched a Brexit Follow Feed which delivers information on stocks, indices and currency pairs directly affected by the UK’s decision to leave the EU.
The free service gives investors the big picture on key events for stocks and other markets that have been identified as Brexit correlated.
Stock sectors include banks, airlines, estate agents and house builders. Barclays (LSE:BARC), EasyJet (LSE:EZJ), Foxtons (LSE:FOXT) and Taylor Wimpey (LSE:TW.) are examples of some of the companies featured.
The Brexit Follow Feed page also includes the currency pairs of GBP/USD, GBP/EUR, GBP/JPY and GBP/RUB, and leading global indices.
Lyxor Asset Management has teamed up with Sandler Capital Management to launch the Lyxor/Sandler US Equity Fund, a US-focused long/short equity strategy, allowing investors to gain exposure to US equities amid an improving outlook for the US economy, while mitigating the impact of volatile market conditions on their portfolio.
The fund focuses on investing across a broad range of US industries and adopts a dynamic long/short approach to identify growing businesses (long positions) and challenged businesses (short positions), ensuring an active management of the US equity market exposure. Risks are managed through diversification, close attention to macro factors and the
Global macro and CTA managers experienced negative returns in January due to long USD positions, especially versus the Euro, according to Lyxor’s latest weekly hedge fund brief.
Meanwhile, fixed income arbitrage, L/S credit, and event-driven managers outperformed both last week and in January overall.
Fixed income arbitrage and L/S Credit funds have been supported lately by both alpha and beta components. The rise in bond yields has created arbitrage opportunities such as the deviation between cash and futures bond prices (the so-called basis). Beta conditions were also supportive as high yield spreads tightened in January. A simple quantitative exercise
Man GLG, the discretionary investment management business of Man Group, has launched the Man GLG Innovation Equity Alternative, a global long-short fund managed by Priya Kodeeswaran.
Available in UCITS format, the fund focuses on opportunities in companies or sectors undergoing change or innovation.
The USD450 million fund seeks out companies within sectors that are particularly susceptible to change and innovation, primarily within the consumer discretionary, technology, telecoms and industrials sectors. Companies in these sectors can be fundamentally mispriced as market consensus can lag the actual or potential effects of disruption, while lower sector correlations allow the manager to build
KKR and Pacific Alternative Asset Management Company (PAAMCO) are teaming up to create a new liquid alternatives investment firm by combining PAAMCO and KKR Prisma.
Under the terms of the agreement, the entire businesses of both PAAMCO and KKR Prisma will be contributed to a newly formed company that will operate independently from KKR, and KKR will retain a 39.9 per cent stake as a long-term strategic partner.
This transaction will create one of the largest firms in the liquid alternatives industry, with over USD30 billion of assets under management or advisement and the ability to fulfil a
GAIN Capital, a provider of online trading services, has signed a non-binding letter of intent to acquire the client base of FXCM's US operations.
Under the letter of intent, customers of FXCM's US regulated business will be transferred to GAIN's retail brand FOREX.com.
The transaction is subject to GAIN and FXCM reaching a definitive agreement and to final regulatory approval. Upon reaching an agreement, the account transfer is expected to occur prior to the end of February.
GAIN Capital is one of the largest providers of retail FX & CFD trading services globally. The company is currently regulated
Cayman Islands-domiciled Montreux Natural Resources fund has come in as the second best-performing hedge fund in Preqin’s Global Hedge Fund report with a return of 142 per cent over the last 12 months, driven by the surging gold price and the performance of assets in which the fund invested.
The USD32 million fund, which generates returns through a range of commodity-related transactions, has during the last 16 months purchased mining interests in Tanzania, east Africa, and a refinery in Guinea, west Africa, at the bottom of the commodity super cycle as other participants were looking to exit.
The firm writes
CME Group has reported revenue of USD913 million and operating income of USD540 million for the fourth quarter of 2016.
Net income was USD373 million and diluted earnings per share were USD1.10.
On an adjusted basis, net income was USD387 million and diluted earnings per share were USD1.14. Financial results presented on an adjusted basis for the fourth quarters of 2016 and 2015 exclude certain items, which are detailed in the reconciliation of non-GAAP results.
Total revenue for full-year 2016 was USD3.6 billion and operating income was USD2.2 billion. Net Income was USD1.53 billion and diluted earnings per
A market correction could provide some longer-term benefits, says Nathan Flanders, managing director, Fitch Ratings…
Mention the words ‘market correction’ and reactions range from mild worry to outright concern among most market participants. However, a number of different types of investment managers may actually welcome hearing those words, as a market correction could provide some longer-term benefits.
Why is it that a market correction, which we define as a temporary decline in asset values of approximately 10 per cent, could benefit a business model primarily predicated on delivering positive returns to investors? The answer is that despite the short-term performance
Euronext has published its first Biotech Barometer, a quarterly tool that offers an insight into major trends in biotechnology companies, which includes only companies offering diagnostics and therapies listed on Euronext markets.
Designed in partnership with Biotech Bourse, the barometer shows performance indicators, investor interest and market sentiment specifically for this sector.
Biotech is a key sector for Euronext: between 2012 and 2016 the number of biotech companies listed on its markets rose from 12 to 45, with a market capitalisation of nearly EUR12 billion. The Biotech Barometer is designed to showcase this fast-moving sector. In addition to providing
